LoadingIDN
Ullman David E reported 5,459 shares of Common Stock, $.001 par value in Intellicheck, Inc. as grants or awards dated 2026-10-08. The Form 4 was disclosed on Oct 13, 2026. These were stock awards, not open-market purchases.
ZVRA
McFarlane Neil F. reported Exercise or conversion in ZEVRA THERAPEUTICS, INC.: 50000 units of Common Stock, dated 2026-10-10. The full Form 4 contains 3 transaction entries.
WS
ADAMS TIMOTHY A reported Grant or award in Worthington Steel, Inc.: 6494 units of Common Shares, dated 2026-10-08. The full Form 4 contains 1 transaction entry.
ARMK
DREILING RICHARD W reported 500 shares of Common Stock in Aramark as grants or awards dated 2026-10-09. The Form 4 was disclosed on Oct 13, 2026. These were stock awards, not open-market purchases.
ESTC
Schuurman Steven reported Sale in Elastic N.V.: 2000000 units of Ordinary Shares, dated 2026-10-12. The full Form 4 contains 1 transaction entry.
HIPO
McCathron Richard reported Sale in Hippo Holdings Inc.: 5000.00 units of Common Stock, dated 2026-10-09. The full Form 4 contains 1 transaction entry.
WS
GILMORE GEOFFREY G reported Grant or award in Worthington Steel, Inc.: 17084 units of Common Shares, dated 2026-10-08. The full Form 4 contains 1 transaction entry.
SUJA
Partin Mark reported 2,381 shares of Class A Common Stock in SUJA LIFE, INC. as grants or awards dated 2026-10-08. The Form 4 was disclosed on Oct 13, 2026. These were stock awards, not open-market purchases.
WS
Heuer Joseph reported Grant or award in Worthington Steel, Inc.: 5485 units of Common Shares, dated 2026-10-08. The full Form 4 contains 1 transaction entry.
ASAN
Rogers Daniel Mark reported Sale in Asana, Inc.: 18021 units of Class A Common Stock, dated 2026-10-09. The full Form 4 contains 1 transaction entry.
CRDO
Fleming Daniel W. reported Sale in Credo Technology Group Holding Ltd: 1687 units of Ordinary Shares, dated 2026-10-08. The full Form 4 contains 5 transaction entries.
WTW
Qureshi Imran Ahmed reported Grant or award in WILLIS TOWERS WATSON PLC: 50.5335 units of Restricted Share Unit (derivative), dated 2026-10-09. The full Form 4 contains 2 transaction entries.
WTW
Pullum Anne reported Grant or award in WILLIS TOWERS WATSON PLC: 50.5329 units of Restricted Share Unit (derivative), dated 2026-10-09. The full Form 4 contains 2 transaction entries.
WTW
Kurpis Joseph Stephen reported Grant or award in WILLIS TOWERS WATSON PLC: 31.0899 units of Restricted Share Unit (derivative), dated 2026-10-09. The full Form 4 contains 1 transaction entry.
AGNT
Pareja Leonardo reported Grant or award in AGNT, Inc.: 573588.00 units of Restricted Stock Units (derivative), dated 2026-10-12. The full Form 4 contains 1 transaction entry.
FENC
Andrade Robert reported Grant or award in FENNEC PHARMACEUTICALS INC.: 3846 units of Common shares, dated 2026-10-12. The full Form 4 contains 1 transaction entry.
FENC
Cioffi Christiana Marie reported Grant or award in FENNEC PHARMACEUTICALS INC.: 3946 units of Common shares, dated 2026-10-12. The full Form 4 contains 1 transaction entry.
WTW
Krasner Andrew Jay reported Grant or award in WILLIS TOWERS WATSON PLC: 64.6829 units of Restricted Share Unit (derivative), dated 2026-10-09. The full Form 4 contains 2 transaction entries.
FENC
Evans Terry L reported Grant or award in FENNEC PHARMACEUTICALS INC.: 2326 units of Common Shares, dated 2026-10-12. The full Form 4 contains 1 transaction entry.
TWST
Laponis Adam reported Sale in Twist Bioscience Corp: 2462 units of Common Stock, dated 2026-10-09. The full Form 4 contains 1 transaction entry.
FENC
Hackman Jeffrey S. reported Grant or award in FENNEC PHARMACEUTICALS INC.: 2224 units of Common Shares, dated 2026-10-12. The full Form 4 contains 1 transaction entry.
IMNN
Faller Douglas Vincent reported 1,249 shares of Common Stock in Imunon, Inc. as grants or awards dated 2026-10-09. The Form 4 was disclosed on Oct 13, 2026. These were stock awards, not open-market purchases.
CHA
HUANG HONGFEI reported Grant or award in Chagee Holdings Ltd.: 675464 units of Employee Stock Options (Right to buy) (derivative), dated 2026-10-12. The full Form 4 contains 1 transaction entry.
FENC
Sayad Pierre Sargis reported Grant or award in FENNEC PHARMACEUTICALS INC.: 3846 units of Common Shares, dated 2026-10-12. The full Form 4 contains 1 transaction entry.
